Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children

European Journal of Immunology

Volumn 40, Issue 5, 2010, Pages 1418-1427

  Monsiváis Urenda, Adriana ^a   Noyola Cherpitel, Daniel ^a   Hernández Salinas, Alba ^a   García Sepúlveda, Christian ^a   Romo, Neus ^b   Baranda, Lourdes ^a   López Botet, Miguel ^b,c   González Amaro, Roberto ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

Author keywords

C type lectins; Human cytomegalovirus; Killer immunoglobulin like receptor (KIR); NK cell; T cell

Indexed keywords

CD161 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; CD94 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2C; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CHILD; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; INFANT; MALE; NATURAL KILLER T CELL; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; T LYMPHOCYTE;

ANTIBODIES, VIRAL; ANTIGENS, CD; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HUMANS; IMMUNOGLOBULIN G; INFANT; KILLER CELLS, NATURAL; MALE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; RECEPTORS, IMMUNOLOGIC; RECEPTORS, NATURAL KILLER CELL; SALIVA; URINE;

EID: 77951733789     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939898     Document Type: Article

References (52)

1. Vivier, E. and Anfossi, N., Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat. Rev. Immunol. 2004. 4: 190-197.
2. Kirwan, S. E. and Burshtyn, D. N., Regulation of natural killer cell activity. Curr. Opin. Immunol. 2007. 19: 46-54.
3. Moretta, L., Biassoni, R., Bottino, C., Mingari, M. C. and Moretta, A., Human NK-cell receptors. Immunol. Today 2000. 21: 420-422.
4. Parham, P., MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 2005. 5: 201-213.
5. Burshtyn, D. N., Scharenberg, A. M., Wagtmann, N., Rajagopalan, S., Berrada, K., Yi, T., Kinet, J. P. and Long, E. O., Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 1996. 4: 77-85. (Pubitemid 26056459)
6. Campbell, K. S., Dessing, M., López-Botet, M., Cella, M. and Colonna, M., Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J. Exp. Med. 1996. 184: 93-100.
7. Brown, D., Trowsdale, J. and Allen, R., The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 2004. 64: 215-225. (Pubitemid 39120446)
8. Colonna, M., Navarro, F., Bellón, T., Llano, M., García, P., Samaridis, J., Angman, L. et al., A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 1997. 186: 1809-1818.
9. Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson, L. and Hsu, M. L., A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997. 7: 273-282. (Pubitemid 27392018)
10. Colonna, M., Nakajima, H. and Cella, M ., A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells. Semin. Immunol. 2000. 12: 121-127.
11. Bellón, T., Kitzig, F., Sayós, J. and López-Botet, M., Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor. J. Immunol. 2002.168: 3351-3359. (Pubitemid 34250398)
12. Chapman, T. L., Heikema, A. P.,West , A. P., Jr. and Bjorkman, P. J., Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity 2000. 13:727-736.
13. Yabe, T., McSherry, C., Bach, F. H., Fisch, P., Schall, R. P., Sondel, P. M. and Houchins, J. P., A multigene family on human chromosome 12 encodes natural killer-cell lectins. Immunogenetics 1993. 37: 455-460. (Pubitemid 23081514)
14. Lazetic, S., Chang, C., Houchins, J. P., Lanier, L. L. and Phillips, J. H., Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 1996. 157: 4741-4745. (Pubitemid 126449546)
15. Carretero, M., Cantoni, C., Bellón, T., Bottino, C., Biassoni, R., Rodríguez, A., Pérez-Villar, J. J. et al., The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 1997. 27: 563-567.
16. Lanier, L. L., Corliss, B., Wu, J. and Phillips, J. H., Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 1998. 8: 693-701. (Pubitemid 28294516)
17. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M. and Geraghty, D. E., HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 1998. 95: 5199-5204.
18. Braud, V. M., Allan, D. S., O'Callaghan, C. A., Soderstrom, K., D'Andrea, A., Ogg, G. S., Lazetic, S. et al., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998. 39: 795-799. (Pubitemid 28099678)
19. Brooks, A. G., Borrego, F., Posch, P. E., Patamawenu, A., Scorzelli, C. J., Ulbrecht, M.,Weiss, E. H. and Coligan, J. E., Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J. Immunol. 1999. 162: 305-313. (Pubitemid 29018934)
20. Borrego, F., Kabat, J., Sanni, T. B., and Coligan, J. E., NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes. J. Immunol. 2002. 169: 6102-6111. (Pubitemid 36903453)
21. +NK cell. J. Immunol. 2009. 182: 829-836.
22. Mingari, M. C., Vitale, C., Cantoni, C., Bellomo, R., Ponte, M., Schiavetti, F., Bertone, S. et al., Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur. J. Immunol. 1997. 27: 1374-1380.
23. Reddehase, M. J., Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat. Rev. Immunol. 2002. 2: 831-844.
24. López-Botet, M., Angulo, A. and Gumá, M., Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. Tissue Antigens 2004. 63: 195-203. (Pubitemid 38297253)
25. Prod'homme, V., Griffin, C., Aicheler, R. J., Wang, E. C., McSharry, B. P., Rickards, C. R., Stanton, R. J. et al., The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1 NK cells. J. Immunol. 2007. 178: 4473-4481.
26. Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V. et al., Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000. 287: 1031. (Pubitemid 30094357)
27. Ulbrecht, M., Martinozzi, S., Grzeschik, M., Hengel, H., Ellwart, J. W., Pla, M. and Weiss, E. H., The human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol. 2000. 164: 5019-5022. (Pubitemid 30305172)
28. Welte, S. A., Sinzger, C., Lutz, S. Z., Singh-Jasuja, H., Sampaio, K. L., Eknigk, U., Rammensee, H.-G. and Steinle, A., Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur. J. Immunol. 2003. 33: 194-203.
29. Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M. and Chalupny, N. J., ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001. 14: 123-133. (Pubitemid 32206515)
30. Chalupny, N. J., Rein-Weston, A., Dosch, S. and Cosman, D., Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem. Biophys. Res. Commun. 2006. 21: 175-181.
31. Stern-Ginossar, N., Elefant, N., Zimmermann, A., Wolf, D. G., Saleh, N., Biton, M., Horwitz, E. et al., Host immune system gene targeting by a viral miRNA. Science 2007. 317: 376-381. (Pubitemid 47106378)
32. Gumá, M., Angulo, A., Vilches, C., Gómez-Lozano, N., Malats, N. and López-Botet, M., Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004. 104: 3664-3671. (Pubitemid 39564443)
33. Gumá, M., Cabrera, C., Erkizia, I., Bofill, M., Clotet, B., Ruiz, L. and López-Botet, M., Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 2006. 194: 38-41.
34. Mela, C. M. and Goodier, M. R., The contribution of cytomegalovirus to changes in NK cell receptor expression in HIV-1-infected individuals. J. Infect. Dis. 2007. 195: 158-159; author reply 159-160.
35. Gumá, M., Budt, M., Sáez, A., Brckalo, T., Hengel, H., Angulo, A. and López-Botet, M., Expansion of CD94/NKG2C+NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006. 107: 3624-3631.
36. Mavilio,D., Lombardo, G., Benjamin, J., Kim, D., Follman,D., Marcenaro, E., O'Shea, M. A. et al., Characterization of CD56-/CD16+natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc. Natl. Acad. Sci. USA 2005. 102: 2886-2891.
37. Lanier, L. L., Chang, C. and Phillips, J. H., Human NKR-P1A: a disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol. 1994. 153: 2417-2428. (Pubitemid 24278110)
38. Takahashi, T., Dejbakhsh-Jones, S. and Strober, S., Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities. J. Immunol. 2006. 176: 211-216. (Pubitemid 43023265)
39. Khakoo, S. I ., Thio, C. L ., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J. et al., HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004. 305: 872-874. (Pubitemid 39038423)
40. Martin, M. P ., Gao, X ., Lee, J. H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K. et al., Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 2002. 31: 429-434.
41. Noyola, D. E., Mejía-Elizondo, A. R., Canseco-Lima, J. M., Allende-Carrera, R., Hernández-Salinas, A. E. and Ramírez- Zacarías, J. L., Congenital cytomegalovirus infection in San Luis Potosi, Mexico. Pediatr. Infect. Dis. J. 2003. 22: 89-90. (Pubitemid 36091786)
42. Zanghellini, F., Boppana, S. B., Emery, V. C., Griffiths, P. D. and Pass, R. F., Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J. Infect. Dis. 1999. 180: 702-707.
43. Steininger. C., Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system. Clin. Microbiol. Infect. 2007. 13: 953-963.
44. Kuijpers, T. W., Baars, P. A., Dantin, C., van den Burg, M., van Lier, R. A. and Roosnek, E., Human NK cells can control CMV infection in the absence of T cells. Blood 2008. 112: 914-915.
45. Sun, J. C., Lanier, L. L., Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity? Eur. J. Immunol. 2009. 39: 2059-2064.
46. Sundström, Y., Nilsson, C., Lilja, G., Kärre, K., Troye-Blomberg, M. and Berg, L., The expression of human natural killer cell receptors in early life. Scand. J. Immunol. 2007. 66: 335-344.
47. Antrobus, R. D., Khan, N., Hislop, A. D., Montamat-Sicotte, D., Garner, L. I., Rickinson, A. B., Moss, P. A. and Willcox, B. E., Virus-specific cytotoxic T lymphocytes differentially express cell-surface leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocompatibility complex molecules. J. Infect. Dis. 2005. 191: 1842-1853.
48. Young, N. T., Uhrberg, M., Phillips, J. H., Lanier, L. L. and Parham, P., Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J. Immunol. 2001. 166: 3933-3941. (Pubitemid 32224920)
49. Wagner, C. S., Riise, G. C., Bergström, T., Kärre, K., Carbone, E. and Berg, L., Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection. J. Immunol. 2007. 178: 3536-3543. (Pubitemid 46417619)
50. Aldemir, H., Prod'homme, V., Dumaurier, M. J., Retiere, C., Poupon, G., Cazareth, J., Bihl, F. and Braud, V. M., Lectin-like transcript 1 is a ligand for the CD161 receptor. J. Immunol. 2005. 176: 7791-7795.
51. Rosen, D. B., Bettadapura, J., Alsharifi, M., Mathew, P. A., Warren, H. S. and Lanier, L. L., Lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J. Immunol. 2005. 176: 7796-7799. (Pubitemid 41798338)
52. Edgar, R. C., MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004. 32: 1792-1797. (Pubitemid 38832724)